Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by ProfCorneliuson May 30, 2020 10:17pm
211 Views
Post# 31092871

RE:RE:RE:RE:RE:RE:RE:BNN BLOOMBERG REPORT ABOUT CANNABIS OUTDOOR GROWING

RE:RE:RE:RE:RE:RE:RE:BNN BLOOMBERG REPORT ABOUT CANNABIS OUTDOOR GROWING
Thorbr55 wrote:
Did they expand on the payback? Is it on par with the Latam investments? Look the only way this makes a business case is if there was a government credit/subsidy involved. By the way what would a typical corporate capital investment payback target be?


I lost any respect I had for you after you admitted to investing in this company but didn't realize that they had cogen plants. The savings of having such dramatically reduce our cost per gram. I left no stone unturned when I invested in this company except for one. Thinking that Vic would do as any sane person would and sign on with Altria at 22 bucks a share. He double crossed Altria and tried to get more and then the short report happened not coincidentally either. I can forgive myself for that costly oversight because Vic fooled and screwed everyone including his very amateur self but what I cannot look past is an investor who doesn't know what they have invested in and why. You are now on ignore with sneeky. All the best. Prof PS Sneekyboots. Try inboxing me. Bet you can't. :)
<< Previous
Bullboard Posts
Next >>